Dascena, Inc.

UEI
LL5MVRM9NKP5
CAGE
78WA3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
dascena.com
Founded
2017
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Dascena, Inc.

Dascena, Inc. is a company that develops machine learning algorithms for healthcare, with a focus on biotechnology and therapeutics for sepsis. It is registered in SAM.gov as a corporate entity, not tax exempt, and is self-certified as a small disadvantaged business and for-profit organization.

Through federal contract awards, Dascena, Inc. has provided machine learning software development for COVID-19 severity predictions to the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response. The contract was awarded under the DRIVe EZ-BAA for rapid deployment of an accessible machine learning software called COVIAGE to predict COVID-19 severity. No set-aside designation was used, and the contract was valued at $171,960.00 with a base period ending January 31, 2022.

Dascena, Inc. has received federal grant awards from the National Institute for Minority Health and Health Disparities (NIMHD) and the National Science Foundation (NSF). The $769,755 NIMHD grant aimed to develop an unbiased machine learning tool for predicting acute coronary syndrome while minimizing bias across patient demographic groups. This supported NIMHD's goals of reducing health disparities through research. The $225,000 NSF grant funded a Phase I SBIR project to develop machine learning for screening acute respiratory distress syndrome in general and COVID-19 patient populations.

Quick answers

What is Dascena, Inc.'s UEI?

Dascena, Inc.'s Unique Entity ID (UEI) in SAM.gov is LL5MVRM9NKP5.

What is Dascena, Inc.'s CAGE code?

Dascena, Inc.'s CAGE code is 78WA3.

What is Dascena, Inc.'s primary NAICS code?

Dascena, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Dascena, Inc. registered in SAM.gov?

Dascena, Inc.'s SAM.gov registration expired on November 21, 2022.

What is Dascena, Inc.'s most recent federal award?

Dascena, Inc.'s most recent federal grant award is Developing an unbiased machine learning tool for prediction of acute coronary syndrome - abstract significance: racial… (R43MD016363), from National Institute for Minority Health and Health Disparities, on September 18, 2021.

On GovTribe

See Dascena, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors